日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance

设计一种治疗性乙肝疫苗以规避免疫耐受

Whitacre, D C; Peters, C J; Sureau, C; Nio, K; Li, F; Su, L; Jones, J E; Isogawa, M; Sallberg, M; Frelin, L; Peterson, D L; Milich, D R

Relation between viral fitness and immune escape within the hepatitis C virus protease

丙型肝炎病毒蛋白酶中病毒适应性和免疫逃逸之间的关系

Söderholm, J; Ahlén, G; Kaul, A; Frelin, L; Alheim, M; Barnfield, C; Liljeström, P; Weiland, O; Milich, D R; Bartenschlager, R; Sällberg, M

The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor alpha mediated liver disease.

丙型肝炎病毒和免疫逃逸:非结构性 3/4A 转基因小鼠对致命的肿瘤坏死因子 α 介导的肝脏疾病具有抵抗力

Frelin L, Brenndörfer E D, Ahlén G, Weiland M, Hultgren C, Alheim M, Glaumann H, Rozell B, Milich D R, Bode J G, Sällberg M

Isolation of a rat liver delta-aminolevulinate dehydrase (ALAD) cDNA clone: evidence for unequal ALAD gene dosage among inbred mouse strains

大鼠肝脏δ-氨基乙酰丙酸脱水酶(ALAD)cDNA克隆的分离:近交系小鼠中ALAD基因剂量不均的证据

Bishop, T R; Cohen, P J; Boyer, S H; Noyes, A N; Frelin, L P